Power and Greed Behind FDA’s Promotion of Remdesivir
Despite studies showing its danger, the U.S. government is pushing a kidney-toxic drug on vulnerable patients Beige Luciano-Adams Jul 31, 2023 Earlier this month the U.S. Food and Drug Administration (FDA) expanded approval for remdesivir, an experimental antiviral drug used for COVID-19 since 2020, for patients with severe […]

















Recent Comments